These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12201954)

  • 1. Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants.
    Morse MA; Rizzieri D; Stenzel TT; Hobeika AC; Vredenburgh JJ; Chao NJ; Clay TM; Mosca PJ; Lyerly HK
    J Hematother Stem Cell Res; 2002 Aug; 11(4):659-68. PubMed ID: 12201954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: correlations with clinical and transplant characteristics.
    Porta MD; Rigolin GM; Alessandrino EP; Maiocchi M; Malcovati L; Vanelli L; Baratè C; Rumi E; Ciccone M; Cuneo A; Lazzarino M; Castoldi G
    Eur J Haematol; 2004 Jan; 72(1):18-25. PubMed ID: 14962258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation.
    Auffermann-Gretzinger S; Eger L; Bornhäuser M; Schäkel K; Oelschlaegel U; Schaich M; Illmer T; Thiede C; Ehninger G
    Transplantation; 2006 Mar; 81(6):866-73. PubMed ID: 16570010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell counts and their subsets during treatment of multiple myeloma.
    Kovarova L; Buchler T; Pour L; Zahradova L; Ocadlikova D; Svobodnik A; Penka M; Vorlicek J; Hajek R
    Neoplasma; 2007; 54(4):297-303. PubMed ID: 17822319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells.
    Hale G; Jacobs P; Wood L; Fibbe WE; Barge R; Novitzky N; Toit C; Abrahams L; Thomas V; Bunjes D; Duncker C; Wiesneth M; Selleslag D; Hidajat M; Starobinski M; Bird P; Waldmann H
    Bone Marrow Transplant; 2000 Jul; 26(1):69-76. PubMed ID: 10918407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients.
    Boeck S; Hamann M; Pihusch V; Heller T; Diem H; Rolf B; Pihusch R; Kolb HJ; Pihusch M
    Bone Marrow Transplant; 2006 Jan; 37(1):57-64. PubMed ID: 16258529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF increases the number of peripheral blood dendritic cells CD16+ and modifies the expression of the costimulatory molecule CD86+.
    Talarn C; Urbano-Ispizua A; Martino R; Batlle M; Fernández-Avilés F; Herrera C; Pérez-Simón JA; Gaya A; Aymerich M; Pétriz J; Marín P; Sierra J; Montserrat E
    Bone Marrow Transplant; 2006 May; 37(9):873-9. PubMed ID: 16547488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation.
    Arpinati M; Chirumbolo G; Urbini B; Martelli V; Stanzani M; Falcioni S; Bonifazi F; Bandini G; Tura S; Baccarani M; Rondelli D
    Bone Marrow Transplant; 2002 Jun; 29(11):887-91. PubMed ID: 12080352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cell recovery after autologous stem cell transplantation.
    Damiani D; Stocchi R; Masolini P; Michelutti A; Sperotto A; Geromin A; Skert C; Cerno M; Michieli M; Baccarani M; Fanin R
    Bone Marrow Transplant; 2002 Sep; 30(5):261-6. PubMed ID: 12209346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution.
    Klangsinsirikul P; Carter GI; Byrne JL; Hale G; Russell NH
    Blood; 2002 Apr; 99(7):2586-91. PubMed ID: 11895797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of alloimmune responses by dendritic cell subsets.
    Lonial S; Torre C; David E; Harris W; Arellano M; Waller EK
    Exp Hematol; 2008 Oct; 36(10):1309-17. PubMed ID: 18620796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patients.
    Kiertscher SM; Gitlitz BJ; Figlin RA; Roth MD
    Int J Cancer; 2003 Nov; 107(2):256-61. PubMed ID: 12949803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
    Arpinati M; Chirumbolo G; Urbini B; Bonifazi F; Bandini G; Saunthararajah Y; Zagnoli A; Stanzani M; Falcioni S; Perrone G; Tura S; Baccarani M; Rondelli D
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):106-15. PubMed ID: 14750076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells.
    Arpinati M; Green CL; Heimfeld S; Heuser JE; Anasetti C
    Blood; 2000 Apr; 95(8):2484-90. PubMed ID: 10753825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor.
    Ferrari S; Rovati B; Porta C; Alessandrino PE; Bertolini A; Collovà E; Riccardi A; Danova M
    Cancer Immunol Immunother; 2003 Jun; 52(6):359-66. PubMed ID: 12664135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral dendritic cell chimerism in allogeneic hematopoietic stem cell recipients.
    Pihusch M; Boeck S; Hamann M; Pihusch V; Heller T; Diem H; Rolf B; Pihusch R; Andreesen R; Holler E; Kolb HJ
    Transplantation; 2005 Sep; 80(6):843-9. PubMed ID: 16210974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
    Dean R; Masci P; Pohlman B; Andresen S; Serafino S; Sobecks R; Kuczkowski E; Curtis J; Maciejewski J; Rybicki L; Kalaycio M; Hsi E; Theil K; Bolwell BJ
    Bone Marrow Transplant; 2005 Dec; 36(12):1049-52. PubMed ID: 16247431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
    Keil F; Prinz E; Moser K; Mannhalter C; Kalhs P; Worel N; Rabitsch W; Schulenburg A; Mitterbauer M; Greinix H
    Transplantation; 2003 Jul; 76(1):230-6. PubMed ID: 12865815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.